Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis

6 Feb 2014

Abstract excerpt

BACKGROUND: To elucidate clinicopathological characteristics of non-small-cell lung carcinoma (NSCLC) cases carrying RET rearrangements causing oncogenic fusions to identify responders to therapy with RET tyrosine kinase inhibitors. METHODS: We investigated 1874 patients with carcinomas, including 1620 adenocarcinomas (ADCs), 203 squamous cell carcinomas (SCCs), 8 large cell carcinomas, and 43 sarcomatoid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Diagnosis and Treatment
Share to Lung Cancer Treatments and Mutations
Share to Metastasis and carcinoma case studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24504365
DOI: 10.1038/bjc.2014.36

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysisPMID 24504365Read ↗

RET-rearranged non-small-cell lung cancer and therapeutic implications.Semantic proximity Read ↗

Current management of RET rearranged non-small cell lung cancerSemantic proximity Read ↗

Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

Clinical and Translational Implications of RET Rearrangements in Non–Small Cell Lung CancerSemantic proximity Read ↗

[Clinicopathological features of patients with RET fusion-positive non-small cell lung cancer].Semantic proximity Read ↗

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

The Genomic Characteristics of RET Fusion Positive Tumors in Chinese Non-Small Cell Lung Cancer (NSCLC) PatientsSemantic proximity Read ↗

A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype.Semantic proximity Read ↗

Clinicopathological and computed tomography features of patients with early-stage non-small-cell lung cancer harboring ALK rearrangement.Semantic proximity Read ↗

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Semantic proximity Read ↗

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?Semantic proximity Read ↗

Clinicopathological Characteristics of RET Rearranged Lung Cancer in European PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.